Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19-Reference-Cited by-同舟云学术

Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19

Published:2020-07-23 Issue:8 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Rhoads Daniel D.¹²^ORCID,Cherian Sree S.¹²,Roman Katharine¹,Stempak Lisa M.¹²,Schmotzer Christine L.¹²,Sadri Navid¹²

Affiliation:

1. Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA

2. Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00760-20

Reference2 articles.

1. Clinical Performance Evaluation of Molecular Diagnostic Tests

2. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Critical Observation of the Application of (SARSCoV)-2 Nucleic Acid Test Behavior in China;American Journal of Health Behavior;2024-04-30

2. The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania;Diagnostics;2024-03-16

3. Analytical performance of the Abbott ID NOW 2.0 assay for SARS-CoV-2 detection in clinical samples from symptomatic patients;Diagnostic Microbiology and Infectious Disease;2024-03

4. Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus;COVID;2024-02-10

5. Implementation and impact of rapid SARS-CoV-2 point of care test on patient flow in the frailty pathway; A quality improvement approach;PLOS ONE;2024-01-02